| Structure | Chemical Name | CAS | MF |
|
SILYLATING MIXTURE FLUKA I ACCORDING TO&
|
318974-69-5
|
C14H33ClN2Si3
|
|
Cyclopropanecarboxylic acid, 2-formyl-3-methyl-, ethyl ester, (1R,3S)-rel- (9CI)
|
318990-36-2
|
C8H12O3
|
|
(9H-Fluoren-9-yl)MethOxy]Carbonyl DL-Ser(Bzl)-OH
|
318996-98-4
|
C25H23NO5
|
|
3-Amino-6-chloro-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide
|
319002-53-4
|
C5H4ClN3O2S2
|
|
Propanoic acid, 2-(1,1-dimethylpropoxy)-, propyl ester, (2S)-
|
319002-92-1
|
C11H22O3
|
|
(R)-BoroSer(OBn)-(+)-Pinanediol-HCl
|
319009-76-2
|
C19H29BClNO3
|
|
(R)-BoroAlg(+)-Pinanediol-hydrochloride
|
319009-90-0
|
C14H25BClNO2
|
|
(R)-BoroAbu-(+)-Pinanediol-HCl
|
319009-92-2
|
C13H25BClNO2
|
|
2'-(TRIFLUOROMETHYL)[1,1'-BIPHENYL]-4-OL
|
319014-58-9
|
C13H9F3O
|
|
4-[(4-methoxyphenyl)amino]benzonitrile
|
319016-04-1
|
C14H12N2O
|
|
Sulfamide, [4-(cyanomethyl)phenyl]- (9CI)
|
319016-44-9
|
C8H9N3O2S
|
|
Ethanone, 1-[4,5-dihydro-3-(2-hydroxyethyl)-5-isoxazolyl]- (9CI)
|
319426-11-4
|
C7H11NO3
|
|
DEXAMETHASONE 21-O-BETA-D-GALACTOPYRANOSIDE
|
319426-57-8
|
C28H40O10
|
|
TETRACYCLINE 10-O-B-D-GALACTOPYRANOSIDE
|
319426-63-6
|
C28H34N2O13
|
|
L-Serine, O-(2-methoxyethyl)- (9CI)
|
319427-45-7
|
C6H13NO4
|
|
1-BOC-4-CYCLOHEPTYLAMINO-PIPERIDINE
|
319427-80-0
|
C17H32N2O2
|
|
Pyr-His-Trp-Ser-Tyr-D-Ala-Leu-Ser-Pro-NHEt
|
319429-24-8
|
C53H71N13O13
|
|
PYRIDINE, 4,4'-[1,1'-BIPHENYL]-4,4'-DIYLBIS-
|
319430-87-0
|
C22H16N2
|
|
8-Oxa-1-azabicyclo[3.2.1]octan-4-one,7-(1-methylethyl)-,(1R,5R,7R)-rel-(9CI)
|
319431-97-5
|
C9H15NO2
|
|
8-Oxa-1-azabicyclo[3.2.1]octan-4-one,7-(1-methylethyl)-,(1R,5R,7S)-rel-(9CI)
|
319432-00-3
|
C9H15NO2
|
|
Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Ser-Pro-NHEt
|
319432-01-4
|
C61H76N14O13
|
|
7-IODO-PYRAZOLO[1,5-A]PYRIDINE
|
319432-22-9
|
C7H5IN2
|
|
Pyrazolo[1,5-a]pyridine, 7-ethenyl-2-methyl-
|
319432-27-4
|
C10H10N2
|
|
Pyrazolo[1,5-a]pyridine, 7-ethynyl-2-methyl-
|
319432-35-4
|
C10H8N2
|
|
Pyrazolo[1,5-a]pyridine-7-carbonitrile
|
319432-36-5
|
C8H5N3
|
|
Pyrazolo[1,5-a]pyridine-7-carbonitrile, 2-methyl-
|
319432-37-6
|
C9H7N3
|
|
PYR-HIS-TRP-SER-HIS-D-ALA-TRP-TYR-PRO-NHET
|
319432-42-3
|
C61H72N16O12
|
|
H-MET-CYS-GLU-LYS-OH
|
319438-96-5
|
C19H35N5O7S2
|
|
S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-hydroxy-2-methylpropanethioate
|
319440-43-2
|
C25H42N7O18P3S
|
|
Thieno[3,2-d]pyrimidine, 4-chloro-2-methyl-
|
319442-16-5
|
C7H5ClN2S
|
|
Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate
|
319442-18-7
|
C9H7ClN2O2S
|
|
Ethyl 4-oxo-3,4-dihydrothieno[3,2-d]pyriMidine-2-carboxylate
|
319442-19-8
|
C9H8N2O3S
|
|
2-(4-CHLOROBENZYLTHIO)-5-NITROBENZALDEHYDE
|
319454-75-6
|
C14H10ClNO3S
|
|
Benzaldehyde, 5-acetyl-2-fluoro- (9CI)
|
319454-87-0
|
C9H7FO2
|
|
Benzaldehyde, 3-acetyl-4-fluoro- (9CI)
|
319455-11-3
|
C9H7FO2
|
|
Benzaldehyde, 4-(1-methylethyl)-, methylenehydrazone (9CI)
|
319456-83-2
|
C11H14N2
|
|
Benzaldehyde, 4-fluoro-, methylenehydrazone (9CI)
|
319456-85-4
|
C8H7FN2
|
|
2-ACETYL-3,6-DIFLUOROBENZOIC ACID
|
319457-34-6
|
C9H6F2O3
|
|
3H-Pyrazol-3-one,4-fluoro-1,2-dihydro-5-(1-methylpropyl)-(9CI)
|
319459-72-8
|
C7H11FN2O
|
|
3H-Pyrazol-3-one,5-butyl-4-fluoro-1,2-dihydro-(9CI)
|
319459-73-9
|
C7H11FN2O
|
|
Axitinib
|
319460-85-0
|
C22H18N4OS
|
|
N-[2-Fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide
|
319460-94-1
|
C26H22FN7O
|
|
3-CARBOXYMETHYL-AZETIDINE-1-CARBOXYLIC ACID BENZYL ESTER
|
319470-14-9
|
C13H15NO4
|
|
3-Methoxy-4-(methoxymethoxy)phenylboronic acid
|
319472-55-4
|
C9H13BO5
|
|
3,6-DIIODO (1H)INDAZOLE
|
319472-78-1
|
C7H4I2N2
|
|
4-bromo-2-chloro-5-methylphenol
|
319473-24-0
|
C7H6BrClO
|
|
4-IODO-7-AZAINDOLE
|
319474-34-5
|
C7H5IN2
|
|
1H-Indazole-6-carboxylic acid, 3-forMyl-
|
319474-35-6
|
C9H6N2O3
|
|
4-(1-PIPERAZINYL)-3-TRIFLUOROMETHYLBENZENAMINE
|
319474-60-7
|
C11H14F3N3
|
|
1H-Pyrazole-5-carboxylicacid,3-methyl-1-(2-propenyl)-(9CI)
|
319474-61-8
|
C8H10N2O2
|
|
(3-BROMOPHENYL)ACETONE OXIME
|
319474-68-5
|
C9H10BrNO
|
|
(3-CHLOROPHENYL)ACETONE OXIME
|
319474-76-5
|
C9H10ClNO
|
|
Cyclopentanecarboxylic acid, 2,3,4-trimethyl-, (1R,2S,3S,4S)-rel- (9CI)
|
319475-00-8
|
C9H16O2
|
|
2H-1,3-Thiazine-4-carboxylicacid,tetrahydro-3-methyl-(9CI)
|
319475-11-1
|
C6H11NO2S
|
|
3-Ethyl-1-vinylimidazolium Bis(trifluoromethanesulfonyl)imide
|
319476-28-3
|
C9H11F6N3O4S2
|
|
2-METHYL-2-(1H-1,2,4-TRIAZOL-1-YL)PROPANOHYDRAZIDE
|
319477-98-0
|
C6H11N5O
|
|
5-BROMOCHROMAN
|
319478-14-3
|
C9H9BrO
|
|
2-{[2-(2-Methoxyphenoxy)ethyl]thio}-1H-benzimidazole
|
319489-19-5
|
C16H16N2O2S
|
|
N-(3-Aminophenyl)-2-(2-methylphenoxy)acetamide
|
319489-63-9
|
C15H16N2O2
|
|
(4S,4'S)-2,2'-[2-phenyl-1-(phenylmethyl)ethylidene]bis[4,5-dihydro-4-phenyl-Oxazole
|
319489-87-7
|
C33H30N2O2
|
|
1H-Benzimidazole-2-propanamine,5-amino-(9CI)
|
319490-25-0
|
C10H14N4
|
|
3-Quinolinecarboxaldehyde,7-ethoxy-1,2-dihydro-2-oxo-(9CI)
|
319490-90-9
|
C12H11NO3
|
|
methyl 3-amino-4,5,6-trimethylthieno[2,3-b]pyridine-2-carboxylate
|
319491-25-3
|
C12H14N2O2S
|
|
N-Des[2-(1-methyl-2-pyrrolidinyl)ethyl] Udenafil
|
319491-68-4
|
C18H23N5O4S
|
|
Spiro[1,3-dioxolane-2,2-[6]oxabicyclo[3.1.0]hexane], (+)-
|
319491-92-4
|
C7H10O3
|
|
7-ISOPROPOXY-6-METHOXY-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBONITRILE
|
319492-96-1
|
C14H14N2O3
|
|
AC-LEHD-CHO
|
319494-38-7
|
C23H34N6O9
|
|
AC-VEID-CHO
|
319494-39-8
|
C22H36N4O9
|
|
3,6- diiodoindazole
|
319672-78-1
|
|
|
1H-Pyrrole-3,4-dicarboxylicacid,2-(3-pyridinyl)-,dimethylester(9CI)
|
319905-65-2
|
C13H12N2O4
|
|
7-Bromo-2-iodo-9,9-dimethyl-9H-fluorene
|
319906-45-1
|
C15H12BrI
|
|
4,6-DIMETHOXY-1-METHYL-1H-INDOLE-2-CARBOXYLIC ACID
|
319906-50-8
|
C12H13NO4
|
|
1-ethyl-4,6-dimethoxy-1H-indole-2-carboxylic acid
|
319906-52-0
|
C13H15NO4
|
|
Carbamic acid, [(3S,4R)-4-methyl-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI)
|
319906-53-1
|
C10H20N2O2
|
|
(DIMETHYLVINYLSILYLOXY)HEPTACYCLOPENT&
|
319910-53-7
|
C39H74O12Si8
|
|
3H-Pyrrolizine-5-carboxaldehyde, 3-oxo- (9CI)
|
319912-39-5
|
C8H5NO2
|
|
2-Propanone,1-(3-ethoxy-4-hydroxyphenyl)-,oxime(9CI)
|
319913-91-2
|
C11H15NO3
|
|
(2-FLUOROPHENYL)ACETONE OXIME
|
319913-98-9
|
C9H10FNO
|
|
(3-HYDROXYPHENYL)ACETONE OXIME
|
319914-13-1
|
C9H11NO2
|
|
3-HYDROXY-4-METHOXYPHENYLACETONE
|
319914-20-0
|
C10H12O3
|
|
6-Hepten-2-one, 4-methyl-, (4R)- (9CI)
|
319915-03-2
|
C8H14O
|
|
1H-Benzimidazole-5-carboxaldehyde,2-propyl-(9CI)
|
319916-64-8
|
C11H12N2O
|
|
1H-Benzimidazole-5-carbonitrile,2-propyl-(9CI)
|
319916-65-9
|
C11H11N3
|
|
2-(Allyloxy)benzyl BroMide
|
319918-15-5
|
C10H11BrO
|
|
4-AMINO-2-NITRO-1-NAPHTHOL
|
319918-83-7
|
C10H8N2O3
|
|
[1,1-Biphenyl]-2,3,4-triol (9CI)
|
319920-97-3
|
C12H10O3
|
|
2,4-DIMETHOXY-6-METHYLBENZONITRILE
|
319921-60-3
|
C10H11NO2
|
|
1H-Pyrazolo[3,4-b]pyridine-4-carbonitrile, 3,6-dimethyl-1-phenyl-
|
319923-88-1
|
C15H12N4
|
|
1H-Pyrazolo[3,4-b]pyridine-4-carbonitrile, 3-methyl-1-phenyl-6-(trifluoromethyl)-
|
319923-89-2
|
C15H9F3N4
|
|
3,6-Dimethyl-1-phenyl-pyrazolo[3,4-b]pyridine-4-carboxylic acid
|
319923-90-5
|
C15H13N3O2
|
|
3,4-Piperidinediol, 5-(hydroxymethyl)-, (3S,4S,5S)- (9CI)
|
319924-35-1
|
C6H13NO3
|
|
2H-1-Benzopyran,3,4-dihydro-6-methyl-2-phenyl-,(2S)-(9CI)
|
319924-88-4
|
C16H16O
|
|
2H-1-Benzopyran-6-carboxaldehyde,3,4-dihydro-2-phenyl-,(2S)-(9CI)
|
319924-94-2
|
C16H14O2
|
|
|
1,5-Naphthalenedisulfonic acid, 3-[[2-(acetylamino)-4-aminophenyl]azo]-, disodium salt, reaction products with 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl] ethyl hydrogen sulfate, hydrolyzed
|
319926-36-8
|
|
|
1-Boc-4-(3,4-dichlorophenyl)piperazine
|
319926-92-6
|
C15H20Cl2N2O2
|
|
H-ILE-THR-GLN-VAL-PRO-PHE-SER-VAL-OH
|
319927-23-6
|
C42H67N9O12
|
|
H-D-MET-MET-MET-OH
|
319927-24-7
|
C15H29N3O4S3
|
|
Pyrrolo[3,2:4,5]imidazo[2,1-c]-1,2,4-triazole (9CI)
|
319929-16-3
|
C6H3N5
|
|
2-(isopropylsulfonyl)ethanamine
|
320337-16-4
|
C5H13NO2S
|
|
Lapatinib IMpurity 8
|
320337-48-2
|
C26H19ClFN3O3
|